NDC 0409-1808 - Novocain
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-1808
- Package NDCs from labels
- 0409-1808-02, 0409-1808-06
- Manufacturer
- Hospira, Inc.
- Effective date
- 2007-04-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NOVOCAIN ® PROCAINE HYDROCHLORIDE INJECTION, USP | Hospira, Inc. | 2007-04-16 | Human prescription drug label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-1808-02 | Novocain | 5 in 1 CONTAINER | INJECTION, SOLUTION | 5 | 1 | |
| 0409-1808-02 | Novocain | 40 in 1 CASE | INJECTION, SOLUTION | 40 | 1 | |
| 0409-1808-06 | Novocain | 50 in 1 TRAY | INJECTION, SOLUTION | 50 | 1 | |
| 0409-1808-06 | Novocain | 10 in 1 CASE | INJECTION, SOLUTION | 10 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Procaine Hydrochloride | ACTIVE INGREDIENT | 95URV01IDQ | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Procaine | ACTIVE MOIETY | 4Z8Y51M438 | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Acetone Sodium Bisulfite | INACTIVE INGREDIENT | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | ||
| Chlorobutanol | INACTIVE INGREDIENT | HM4YQM8WRC | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Hydrochloric Acid | INACTIVE INGREDIENT | QTT17582CB | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | NOVOCAIN (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Heparin Sodium | HEPARIN SODIUM | Hospira, Inc. | c8c4edd2-ee9e-4558-6b8c-b83adc242a0a | 2026-08-25 | Warnings, Adverse reactions | Hospira, Inc. |
| Magnesium Sulfate in Water | MAGNESIUM SULFATE IN WATER | Hospira, Inc. | 22ca78b4-f5a3-4144-cf89-5f633acf1e6d | 2026-08-24 | Warnings, Adverse reactions | Hospira, Inc. |
| Fentanyl Citrate | FENTANYL CITRATE | Hospira, Inc. | bfa8018a-4cbc-434b-e09e-782872b0340a | 2026-08-24 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Magnesium Sulfate in Dextrose | MAGNESIUM SULFATE IN DEXTROSE | Hospira, Inc. | 03ebeabb-8386-4af4-3086-bdf3c3fc4a5a | 2026-08-24 | Warnings, Adverse reactions | Hospira, Inc. |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | ad1ef0a8-88db-4648-c098-d009eaeb4e5b | 2026-08-20 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Chloride | SODIUM CHLORIDE | YYBA CORP | 597f3347-647c-3545-e063-6294a90abab2 | 2026-08-20 | Warnings | Sodium Chloride |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 2e5fe9f4-78e5-4af4-8bf9-9680e5dc5e88 | 2026-08-20 | Warnings, Adverse reactions | Sodium Chloride |
| QUELICIN | SUCCINYLCHOLINE CHLORIDE | Hospira, Inc. | fb08161e-7711-406d-e7b3-ea4515c07983 | 2026-08-18 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| PROPOFOL | PROPOFOL | Hospira, Inc. | 28d7ba00-f824-4e55-139a-03f509c099db | 2026-08-13 | Warnings, Adverse reactions | Hospira, Inc. |
| MIDAZOLAM | MIDAZOLAM HYDROCHLORIDE | Hospira, Inc. | b95415fa-17c2-42ab-a6b0-e628d01c94ed | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Midazolam | MIDAZOLAM HYDROCHLORIDE | Hospira, Inc. | 1abda8b8-48a8-4995-af86-39220d1aa240 | 2026-08-12 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Vitamin K1 | PHYTONADIONE | Hospira, Inc. | e8808230-2c44-44c6-8cab-8f29b6b34051 | 2026-08-09 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Oxaliplatin | OXALIPLATIN | Hospira, Inc. | e51a62ba-d163-4c57-835c-8c86cf097e40 | 2026-08-07 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | 3b2dd84e-cee8-4e58-d494-395a65a353a0 | 2026-08-05 | Warnings, Adverse reactions | Hospira, Inc. |
| Lidocaine Hydrochloride | LIDOCAINE HYDROCHLORIDE | Hospira, Inc. | 9c18eaf1-4a0b-4916-70b2-88a827494711 | 2026-08-05 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Medical Care de Mexico, S.A. de C.V. | 9a1220fb-6853-45ae-838c-10d8596e1af7 | 2026-07-27 | Warnings, Adverse reactions | Sodium Chloride |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | af5cdf1a-19f4-11e2-892e-0800200c9a66 | 2026-07-27 | Warnings, Adverse reactions | Sodium Chloride |
| Ketorolac Tromethamine | KETOROLAC TROMETHAMINE | Hospira, Inc. | 8accbb78-fc64-45d5-69b0-35c23a1d2a2e | 2026-07-20 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Hospira, Inc. | b01aaa02-8f1d-4b57-96a5-337503428af1 | 2026-07-20 | Warnings, Adverse reactions | Hospira, Inc. |
| DEMEROL | MEPERIDINE HYDROCHLORIDE | Hospira, Inc. | b31d1308-28c3-43f4-e0a6-2f3ed76b8975 | 2026-07-20 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.